Prostate Cancer - Results from #24100

Risk stratification after biochemical failure following curative treatment of locally advanced prostate cancer: Data from the TROG 96.01 trial - Abstract February 13, 2013

Trans-anal rectoscopic ball diathermy (TARD) for radiotherapy induced haemorrhagic telangectasia : A safe and effective treatment - Abstract February 13, 2013

Diagnostic tests in urology: Magnetic resonance imaging (MRI) for the staging of prostate cancer - Abstract February 13, 2013

Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort - Abstract February 13, 2013

Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population - Abstract February 13, 2013

Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria - Abstract February 13, 2013

Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors February 13, 2013

Masculinities and patient perspectives of communication about active surveillance for prostate cancer - Abstract February 13, 2013

Familial prostate cancer: The damage done and lessons learnt - Abstract February 12, 2013

Aberrant PSA glycosylation-a sweet predictor of prostate cancer - Abstract February 12, 2013

Edema-induced changes in tumor cell surviving fraction and tumor control probability in 131Cs permanent prostate brachytherapy implant patients - Abstract February 12, 2013

Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: A randomized controlled trial - Abstract February 12, 2013

Active surveillance for prostate cancer: Overview and update - Abstract February 12, 2013

Radium-223 chloride: A potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease - Abstract February 12, 2013

The impact of prostate volume, number of biopsy cores, and AUA symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial Risk Calculator - Abstract February 11, 2013

Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy - Abstract February 11, 2013

A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer - Abstract February 11, 2013

Comparison of preplanning and intraoperative planning for I-125 prostate brachytherapy - Abstract February 11, 2013

Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: Results from the Prostate Cancer Prevention Trial - Abstract February 11, 2013

"The only way I know how to live is to work": A qualitative study of work following treatment for prostate cancer - Abstract February 11, 2013

Page 1206 of 1447